Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities Growth (1y) (2012 - 2025)
Catalyst Pharmaceuticals (CPRX) Cash from Investing Activities Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 62.68% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -674.01% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -166.24% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63.64% |
| Jun 30, 2025 | -160.00% |
| Dec 31, 2024 | 99.77% |
| Sep 30, 2024 | 99.72% |
| Mar 31, 2024 | 99.88% |
| Sep 30, 2023 | -70,215.91% |
| Sep 30, 2022 | -94.12% |
| Sep 30, 2021 | 99.32% |
| Mar 31, 2021 | -238.22% |
| Sep 30, 2020 | -298.35% |
| Mar 31, 2020 | -52.15% |
| Dec 31, 2019 | 123.85% |
| Sep 30, 2019 | -33.39% |
| Jun 30, 2019 | -100.41% |
| Mar 31, 2019 | 132.81% |
| Dec 31, 2018 | 23,165.63% |
| Sep 30, 2018 | 25,492.94% |
| Jun 30, 2018 | -280,642.10% |
| Mar 31, 2018 | -95,985.96% |
| Dec 31, 2017 | -89.63% |